Taiwan · Delayed Price · Currency is TWD InPsytech Statistics
Total Valuation
InPsytech has a market cap or net worth of TWD 11.11 billion. The enterprise value is 10.43 billion.
| Market Cap | 11.11B |
| Enterprise Value | 10.43B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Jul 22, 2026 |
Share Statistics
InPsytech has 30.04 million shares outstanding.
| Current Share Class | 30.04M |
| Shares Outstanding | 30.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.20% |
| Owned by Institutions (%) | 1.80% |
| Float | 9.87M |
Valuation Ratios
The trailing PE ratio is 66.31.
| PE Ratio | 66.31 |
| Forward PE | n/a |
| PS Ratio | 18.49 |
| PB Ratio | 12.38 |
| P/TBV Ratio | 12.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3,633.32 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 64.39 |
| EV / Sales | 17.36 |
| EV / EBITDA | 61.61 |
| EV / EBIT | 63.31 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.54
| Current Ratio | 8.54 |
| Quick Ratio | 7.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 41,198.25 |
Financial Efficiency
Return on equity (ROE) is 24.90% and return on invested capital (ROIC) is 182.00%.
| Return on Equity (ROE) | 24.90% |
| Return on Assets (ROA) | 12.48% |
| Return on Invested Capital (ROIC) | 182.00% |
| Return on Capital Employed (ROCE) | 18.31% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 6.53M |
| Profits Per Employee | 1.76M |
| Employee Count | 92 |
| Asset Turnover | 0.73 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, InPsytech has paid 32.82 million in taxes.
| Income Tax | 32.82M |
| Effective Tax Rate | 16.84% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 405.78 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 39.50 |
| Average Volume (20 Days) | 31,574 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InPsytech had revenue of TWD 601.07 million and earned 162.04 million in profits. Earnings per share was 5.58.
| Revenue | 601.07M |
| Gross Profit | 601.07M |
| Operating Income | 164.79M |
| Pretax Income | 194.86M |
| Net Income | 162.04M |
| EBITDA | 169.35M |
| EBIT | 164.79M |
| Earnings Per Share (EPS) | 5.58 |
Balance Sheet
The company has 681.47 million in cash and no debt, with a net cash position of 681.47 million or 22.69 per share.
| Cash & Cash Equivalents | 681.47M |
| Total Debt | n/a |
| Net Cash | 681.47M |
| Net Cash Per Share | 22.69 |
| Equity (Book Value) | 897.71M |
| Book Value Per Share | 29.89 |
| Working Capital | 824.85M |
Cash Flow
In the last 12 months, operating cash flow was 3.06 million and capital expenditures -5.56 million, giving a free cash flow of -2.50 million.
| Operating Cash Flow | 3.06M |
| Capital Expenditures | -5.56M |
| Depreciation & Amortization | 4.56M |
| Net Borrowing | n/a |
| Free Cash Flow | -2.50M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 100.00%, with operating and profit margins of 27.42% and 26.96%.
| Gross Margin | 100.00% |
| Operating Margin | 27.42% |
| Pretax Margin | 32.42% |
| Profit Margin | 26.96% |
| EBITDA Margin | 28.17% |
| EBIT Margin | 27.42% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 0.27% |
| Earnings Yield | 1.46% |
| FCF Yield | -0.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InPsytech has an Altman Z-Score of 2.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.38 |
| Piotroski F-Score | 3 |